Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Infection
83%
Infectious Disease
80%
Human Immunodeficiency Virus
78%
COVID-19
75%
Severe Acute Respiratory Syndrome Coronavirus 2
75%
In Vitro
71%
Minimum Inhibitory Concentration
68%
Immunogenicity
61%
Adoptive Immunity
46%
Enterococcus faecalis
40%
Gram-Positive Bacteria
40%
Enterococcus
36%
CD4 Lymphocyte Count
33%
COVID-19 Vaccination
31%
Staphylococcus Aureus
30%
Normal Human
29%
Streptococcus pneumonia
29%
Streptococcus
29%
Kidney Transplantation
29%
Humoral Immunity
28%
Enterococcus faecium
27%
Ribonucleic Acid
27%
Immune Response
26%
Susceptibility
25%
CD4
23%
Booster Dose
22%
Titer
22%
Staphylococcus
22%
Urinary Tract
20%
Virus
19%
Prevalence
18%
Influenza A Virus (H1N1)
17%
Enterobacteriaceae
17%
Enterobacterales
17%
Loop-Mediated Isothermal Amplification
17%
Influenza
17%
Immunoglobulin M Deficiency
17%
Viral Load
17%
Adenoviridae
17%
Pyrosequencing
17%
Klebsiella pneumoniae
17%
Severe Acute Respiratory Syndrome
17%
Peptoclostridium difficile
17%
Immune Reconstitution
17%
Abscess
17%
Brucella
17%
Clostridium
17%
Escherichia coli
17%
Acinetobacter Baumannii
17%
Gram Positive Cocci
17%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Infection
63%
Hospital Infection
61%
Antimicrobial Agent
41%
Antibiotic Resistance
39%
Prevalence
36%
Escherichia Coli Pneumonia
35%
Penicillinase
35%
Nonnucleoside Reverse Transcriptase Inhibitor
35%
Nevirapine
35%
Klebsiella pneumoniae
35%
Rash
35%
Antiinfective Agent
34%
Diseases
25%
Vancomycin
24%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
24%
Antibiotics
22%
Ceftriaxone
21%
Bacterium
21%
Extended Spectrum Beta Lactamase
20%
Diarrhea
20%
Indinavir
19%
Acinetobacter Baumannii
19%
Occupational Exposure
17%
Clostridium Difficile Infection
17%
Sultamicillin
17%
Burkholderia Cepacia Complex
17%
Clavulanic Acid
17%
Abscess
17%
Efavirenz
17%
Chlorhexidine
17%
Brucellosis
17%
Normal Human
17%
Tuberculosis
17%
Tigecycline
17%
Respiratory Tract Infection
17%
Amoxicillin
17%
Bioequivalence
17%
Persistent Virus Infection
17%
Carbapenemase
17%
Pharmacokinetics
17%
Enterobacteriaceae
17%
Human Immunodeficiency Virus Infection
14%
Carbapenemase Producing Enterobacteriaceae
14%
Clostridium
12%
Pneumonia
12%
Imipenem
12%
Meropenem
12%
Cryptococcosis
11%
Proteinase Inhibitor
10%
Medicine and Dentistry
Infection
61%
Kidney Graft
53%
Surgical Infection
53%
Human Immunodeficiency Virus
51%
Health Care Personnel
38%
COVID-19
35%
Cohort Effect
35%
Penicillinase
35%
Antiretroviral Therapy
35%
Prospective Study
22%
Gram-Negative Bacteria
21%
Klebsiella pneumoniae
20%
Prevalence
19%
Urinary Tract Infection
19%
Kidney Transplantation
18%
Carbapenem
17%
Randomized Controlled Trial
17%
Antibiotic Resistance
17%
Catheter Infection
17%
Antibiotic Therapy
17%
Thyroid Gland
17%
Cephalosporin
17%
Abscess
17%
Surgeon
17%
Tuberculosis
17%
Meningococcal Disease
17%
Thyroglossal Cyst
17%
Escherichia Coli Pneumonia
17%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
17%
Diarrhea
17%
Post-Exposure Prophylaxis
17%
Chlorhexidine
17%
Nonnucleoside Reverse Transcriptase Inhibitor
17%
Occupational Exposure
17%
Diagnosis of Clostridium Difficile
17%
Burkholderia Cepacia Complex
17%
Catheter Removal
17%
Messenger RNA
17%
Emerging Infectious Disease
17%
Brucellosis
17%
Virus Vector
17%
Clostridium Difficile Infection
17%
Extended Spectrum Beta Lactamase
14%
Clostridium
12%
Infection Control
12%
Cryptococcosis
11%
Human Immunodeficiency Virus Infection
11%
Infection Prevention
10%
Pneumonia
10%
Immune Reconstitution Inflammatory Syndrome
8%